Artificial viruses: a nanotechnological approach to gene delivery

Nanotechnology is a rapidly expanding multidisciplinary field in which highly sophisticated nanoscale devices are constructed from atoms, molecules or (macro)molecular assemblies. In the field of gene medicine, systems for delivering nucleic acids are being developed that incorporate virus-like functions in a single nanoparticle. Although their development is still in its infancy, it is expected that such artificial viruses will have a great impact on the advancements of gene therapeutics.

[1]  R. Scheule.  The role of CpG motifs in immunostimulation and gene therapy. , 2000, Advanced drug delivery reviews.

[2]  B. Houk,et al.  Pharmacokinetics of Plasmid DNA in the Rat , 2004, Pharmaceutical Research.

[3]  Wenjin Guo,et al.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. , 2001, Bioconjugate chemistry.

[4]  A. Villaverde,et al.  Modular protein engineering for non-viral gene therapy. , 2004, Trends in biotechnology.

[5]  J. Zabner,et al.  A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia , 1997, Gene Therapy.

[6]  J. Behr,et al.  Development of plasmid and oligonucleotide nanometric particles , 2002, Gene Therapy.

[7]  N. Ueno,et al.  Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Yuichi Yamasaki,et al.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. , 2004, Journal of the American Chemical Society.

[9]  G. Amidon,et al.  Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential , 2003, Gene Therapy.

[10]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[11]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[12]  R. Crystal,et al.  Cytoplasmic Dynein Mediates Adenovirus Binding to Microtubules , 2004, Journal of Virology.

[13]  D. Escande,et al.  Ca2+‐sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids , 2001, The journal of gene medicine.

[14]  L. Rozamus,et al.  Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. , 2005, Blood.

[15]  D. Crommelin,et al.  An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems , 2005, The journal of gene medicine.

[16]  T. Clackson,et al.  Regulated gene expression systems , 2000, Gene Therapy.

[17]  A. Verkman,et al.  Actin Cytoskeleton as the Principal Determinant of Size-dependent DNA Mobility in Cytoplasm , 2005, Journal of Biological Chemistry.

[18]  N. Yew.  Controlling the kinetics of transgene expression by plasmid design. , 2005, Advanced drug delivery reviews.

[19]  J. Hagstrom,et al.  Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Harbottle,et al.  Development of a Self-assembling Nuclear Targeting Vector System Based on the Tetracycline Repressor Protein* , 2004, Journal of Biological Chemistry.

[21]  J. Olson,et al.  A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[23]  Y. Aoyama,et al.  Encapsulation of DNA with neutral glycocluster nanoparticles. A step toward artificial viruses. , 2003, Nucleic acids research. Supplement.

[24]  J. Albar,et al.  Recognition of novel viral sequences that associate with the dynein light chain LC8 identified through a pepscan technique , 2003, FEBS letters.

[25]  Xin Wen,et al.  Molecular motors as drug delivery vehicles. , 2005, Drug discovery today. Technologies.

[26]  A. Kabanov,et al.  DNA complexes with polycations for the delivery of genetic material into cells. , 1995, Bioconjugate chemistry.

[27]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[28]  D. Crommelin,et al.  Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[29]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. F. Anderson.  Assessment of adenoviral vector safety and toxicity: Report of the National Institutes of Health Recombinant DNA Advisory Committee , 2002 .

[31]  S. W. Kim,et al.  Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[32]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[33]  M. Vert,et al.  Biocompatibility of Polycations: In Vitro Agglutination and Lysis of Red Blood Cells And In Vivo Toxicity , 2002, Journal of drug targeting.

[34]  Christine Kinnon,et al.  Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans , 2006, Pediatrics.

[35]  A. Mortellaro,et al.  Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning , 2002, Science.

[36]  J. Thompson,et al.  Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  G. Ghosh,et al.  Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. , 2005, Human gene therapy.

[38]  R. Gonzalez,et al.  Efficacy and safety of HLA-B7/β-2 microglobulin plasmid DNA/lipid complex (Allovectin-7®) in patients with metastatic melanoma , 2003, Expert opinion on biological therapy.

[39]  G. Zuber,et al.  Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid. , 2003, Angewandte Chemie.

[40]  N. Pante,et al.  Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. , 2002, Molecular biology of the cell.

[41]  T. Mayumi,et al.  Optimization of transcriptional regulatory elements for constructing plasmid vectors. , 2001, Gene.

[42]  L. Seymour,et al.  Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo , 2001, Gene Therapy.

[43]  A. Villaverde,et al.  Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. , 2003, Human gene therapy.

[44]  Ann Logan,et al.  A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids , 2005, Nucleic acids research.

[45]  S. Wadler,et al.  Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  G M Edelman,et al.  Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Mario R. Capecchi,et al.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells , 1980, Cell.

[48]  A. Logan,et al.  Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. , 2004, Bioconjugate chemistry.

[49]  Wagner,et al.  Application of membrane-active peptides for nonviral gene delivery. , 1999, Advanced drug delivery reviews.

[50]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Fischer,et al.  Gene therapy for severe combined immunodeficiency. , 2005, Annual review of medicine.

[52]  H. Lipps,et al.  Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.

[53]  U. Kutay,et al.  Transport between the cell nucleus and the cytoplasm. , 1999, Annual review of cell and developmental biology.

[54]  Kazuo Maruyama,et al.  Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. , 2004, Biochemistry.

[55]  Wim E Hennink,et al.  Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells , 2001, Cancer Gene Therapy.

[56]  R K Jain,et al.  Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Clancy,et al.  Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. , 2004, Chest.

[58]  D. Crommelin,et al.  Steric stabilization of poly(2‐(dimethylamino)ethyl methacrylate)‐based polyplexes mediates prolonged circulation and tumor targeting in mice , 2004, The journal of gene medicine.

[59]  W. Hennink,et al.  A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. , 2003, Bioconjugate chemistry.

[60]  K. Luby-Phelps,et al.  Cytoarchitecture and physical properties of cytoplasm: volume, viscosity, diffusion, intracellular surface area. , 2000, International review of cytology.

[61]  A. Stopeck,et al.  Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma , 2001 .

[62]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[63]  Marie Carrière,et al.  NLS bioconjugates for targeting therapeutic genes to the nucleus. , 2003, Advanced drug delivery reviews.

[64]  K. Berg,et al.  Photochemically Enhanced Gene Delivery of EGF Receptor-targeted DNA Polyplexes , 2004, Journal of drug targeting.

[65]  S. Brüsselbach,et al.  Highly efficient transduction of endothelial cells by targeted artificial virus-like particles , 2001, Cancer Gene Therapy.

[66]  Jaroslav Pelisek,et al.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.